Cited by 116Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain

Open access
Welikovitch, Lindsay A., Do Carmo, Sonia, Maglóczky, Zsófia, Malcolm, Janice C., Lőke, János, Klein, William L., Freund, Tamás, Cuello, A. Claudio·2020·Proceedings of the National Academy of Sciences

Abstract

Significance: This work provides evidence that soluble and oligomeric amyloid protein stokes neuronal inflammation during the earliest stages of Alzheimer’s disease. Identifying neuron-derived factors that engage the brain’s immune system will provide insight into how vulnerable neurons might interact with other immune cells to propagate cytotoxic signaling cascades and cellular dysfunction during disease development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1914593117

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Soluble and oligomeric amyloid protein-burdened neurons exhibit a unique inflammatory profile; this neuron-specific inflammatory response may precede insoluble Aβ plaque and tau tangle formation, implicating intraneuronal Aβ accumulation as a very early event in AD development and suggesting a significant immunological component to AD pathogenesis.

    “Recently, Welikovitch et al. found that soluble and oligomeric amyloid protein-burdened neurons exhibited a unique inflammatory profile. This neuron-specific inflammatory response may even precede insoluble Aβ plaque and tau tangle formation, implicating the intraneuronal accumulation of Aβ as a very early event during AD development and suggesting that there is a significant immunological comp”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [47]

  • Observations of neuron-derived immune signaling at early stages of neurodegenerative disease indicate that this may play a role in disease progression.

    “Indeed, observations of neuron‐derived immune signaling at early stages of neurodegenerative disease indicate that this may play a role in disease progression (Dutta et al, 2020; Welikovitch et al, 2020).”

    From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Welikovitch et al, 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Welikovitch, L. A., Do Carmo, S., Maglóczky, Z., Malcolm, J. C., Lőke, J., Klein, W. L., Freund, T., & Cuello, A. C.
Affiliations
  • McGill University (CA)
  • Department of Pharmacology and Therapeutics, McGill University, Montreal, QC H3G 1Y6, Canada;
  • HUN-REN Institute of Experimental Medicine (HU)
  • Szent Borbála Kórház (HU)
  • Northwestern University (US)
  • University of Oxford (GB)
Corresponding author
Cuello, A. Claudio
Venue
Proceedings of the National Academy of Sciences
Published
2020-03-06
Volume
117
Issue
12
Pages
6844-6854
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W3009672833
Cited by
116
References
93
Citations by year
2026: 15 · 2025: 15 · 2024: 19 · 2023: 15 · 2022: 20 · 2021: 21 · 2020: 10 · 2019: 1
FWCI
9.92
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
Funders
  • Gouvernement du Canada | Canadian Institutes of Health Research (PJT-364544)
  • National Research, Development and Innovation Office (2017-1.2.1-NKP-2017-00002)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, intraneuronal amyloid-beta, neuroinflammation, microglial activation, amyloid-beta oligomers, tau tangles, laser microdissection, human brain
MeSH terms
Alzheimer Disease, Amyloidosis, Animals, Brain, Disease Models, Animal, Female, Humans, Inflammation, Male, Neurons, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Rats, Rats, Transgenic, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review